Beauty Stack

GHK-Cu — 100 mg
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a complex formed by the GHK tripeptide bound to a copper ion. GHK occurs naturally in the human body and has been studied for its involvement in mechanisms related to the extracellular matrix, fibroblast activity, and tissue remodeling. Experimental studies describe its influence on the synthesis of collagen, elastin, and glycosaminoglycans, as well as processes associated with tissue repair. However, the available evidence varies considerably depending on the formulation and route of administration; for systemic injectable use, clinical data are more limited.

Retatrutide — 40 mg
Retatrutide is an experimental peptide developed as a triple agonist of the GLP-1, GIP, and glucagon receptors. This combination of hormonal pathways is being investigated primarily for its effects on appetite control, energy intake, body weight, and metabolism. In 2026, Phase 3 results from the TRIUMPH clinical development program were announced; however, Eli Lilly states that Retatrutide has not yet been approved by any regulatory authority and remains an investigational drug. Lilly

Composition

01 vial — GHK-Cu 100 mg
01 vial — Retatrutide 40 mg

Important note: Bacteriostatic water is not included. Bacteriostatic water or any other diluent required for reconstitution must be purchased separately.